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pproaches with high spatial and temporal resolution
are required to understand the regulation of nonmus-
 
cle myosin II in vivo
 
.
 
 Using ﬂuorescence resonance
energy transfer we have produced a novel biosensor allowing
simultaneous determination of myosin light chain kinase
 
(MLCK) localization and its [Ca
 
2
 
 
 
]
 
4
 
/calmodulin-binding
state in living cells. We observe transient recruitment of
diffuse MLCK to stress ﬁbers and its in situ activation before
contraction. MLCK is highly active in the lamella of migrating
cells, but not at the retracting tail. This unexpected result
A
 
highlights a potential role for MLCK-mediated myosin
contractility in the lamella as a driving force for migration.
During cytokinesis, MLCK was enriched at the spindle
equator during late metaphase, and was maximally acti-
vated just before cleavage furrow constriction. As furrow
contraction was completed, active MLCK was redistributed
to the poles of the daughter cells. These results show MLCK
is a myosin regulator in the lamella and contractile ring,
and pinpoints sites where myosin function may be mediated
by other kinases.
 
Introduction
 
Phosphorylation of the 20-kD regulatory light chain (RLC)*
regulates nonmuscle myosin II activity. RLC phosphoryla-
tion sites can be categorized into inhibitory and activating
based on their effects on myosin function. Phosphorylation
of Ser-19 and Thr-18 stimulates myosin activity, whereas
Ser-1, Ser-2, and Thr-9 phosphorylation is inhibitory.
Ser-19 can be phosphorylated by several kinases, including
myosin light chain kinase (MLCK) (Sellers et al., 1981;
Ikebe et al., 1986), Rho kinase (Amano et al., 1996), and
p21-activated kinase (PAK) (Chew et al., 1998; Zeng et al.,
2000). MLCK also phosphorylates RLC at Thr-18 (Ikebe
et al., 1986). Thr18-ser19 diphosphorylation maximally
activates myosin ATPase in vitro (Sellers et al., 1981),
and produces maximal isometric tension development in
thrombin-stimulated endothelial cells (Goeckeler and Wy-
solmerski, 1995). Phosphorylation of RLC at Ser-1, Ser-2, or
Thr-9 by protein kinase C (Ikebe et al., 1987) or Cdc2 ki-
nase (Satterwhite et al., 1992; Mishima and Mabuchi, 1996)
inhibits myosin activity and decreases the Km of MLCK for
RLC (Turbedsky et al., 1997).
The kinases that phosphorylate the RLC are regulated
 
by distinct upstream signals, such as [Ca
 
2
 
 
 
]
 
4
 
/calmodulin
and Rho family GTPases. In addition, many of these
pathways interact. For example, cdc42-activated PAK
phosphorylates RLC at Ser-19 (Chew et al., 1998; Zeng et
al., 2000) and inhibits MLCK, preventing Thr-18 phos-
phorylation (Sanders et al., 1999; Goeckeler et al., 2000).
This complexity suggests that cells spatially and tempo-
rally compartmentalize their signals. How these different
kinases are targeted to their sites of action remains unre-
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solved, in part due to our inability to follow these molecu-
lar events dynamically.
MLCK is a [Ca
 
2
 
 
 
]
 
4
 
/calmodulin-dependent kinase impli-
cated in nonmuscle contraction (Goeckeler and Wysolmer-
ski, 1995), cytokinesis (Poperechnaya et al., 2000), stress
fiber formation (Chrzanowska-Wodnicka and Burridge,
1996), and motility (Kishi et al., 2000). The MLCK gene
encodes two different kinases, a 210-kD MLCK (MLCK
 
210
 
)
expressed primarily in nonmuscle cells, and a differentially
spliced isoform of 108–125 kD, MLCK
 
125 
 
(Poperechnaya et
al., 2000). Although previous immunolocalization studies
have localized MLCK to stress fibers as well as the cleavage
furrow of dividing cells (de Lanerolle et al., 1981; Guerriero
et al., 1981), the dynamics of MLCK activation in these re-
gions is unknown. The formation and maintenance of stress
fibers are believed to require RLC phosphorylation (Chrza-
nowska-Wodnicka and Burridge, 1996), consistent with the
stress fiber association of MLCK. However, despite localiza-
tion of MLCK to stress fibers, myosin is not fully activated
as further contraction can be induced. This suggests myosin
can be further potentiated to produce maximal contraction.
In addition, we do not know if MLCK activation precedes
or follows stress fiber localization. The convergence of mul-
tiple signals on myosin highlights the possibility of regional-
ized myosin regulation by distinct pathways. These unre-
solved issues underscore the need to dissect these pathways
spatially and temporally. As the best characterized RLC ki-
nase, MLCK is an ideal target for dynamic localization of ac-
tivation state.
Using fluorescence resonant energy transfer (FRET) be-
tween blue (BFP) and green (GFP) fluorescent proteins, Ro-
moser et al. (1997) developed a fluorescent indicator protein
(FIP) that detected [Ca
 
2
 
 
 
]
 
4
 
/calmodulin changes in live cells.
Here we report the engineering of a novel biosensor, created
by fusing the FIP to the MLCK COOH terminus, that de-
tects the calmodulin binding state of MLCK. Since [Ca
 
2
 
 
 
]
 
4
 
/
calmodulin-binding activates MLCK, this sensor provides a
representation of the activation state of MLCK. Using this
approach, we observed that localized MLCK activation
along stress fibers precedes cell contraction, demonstrating
that MLCK activity can be modulated in situ on stress fibers
to mediate the extent of myosin contractility. Activated
Figure 1. MLCK-FIP is a FRET-based [Ca
2 ]4/calmodulin sensor with activity and regulation similar to wild-type MLCK. (A) Schematic 
diagram of MLCK-FIP. The fluorescent indicator protein (FIP) consists of BFP linked to GFP via the [Ca
2 ]4/calmodulin-binding domain derived 
from MLCK. In the absence of [Ca
2 ]4/calmodulin, the coiled [Ca
2 ]4/calmodulin binding domain allows FRET between the fluorophores. 
When [Ca
2 ]4/calmodulin (yellow cylinder) is present, it binds and activates MLCK and binds between the fluorophores disrupting FRET. 
(B) MLCK-FIP shows [Ca
2 ]4/calmodulin dependent kinase activity. Lysates from mock-transfected COS-7 cells or cells transiently expressing 
MLCK-FIP, wild-type MLCK were tested for their ability to phosphorylate RLC in a [Ca
2 ]4/calmodulin-dependent fashion. Endogenous kinase 
activity was evident only after prolonged exposure of the autoradiograph. (C) MLCK-FIP phosphorylates RLC at rates similar to wild-type 
MLCK. The activity of immunoprecipitated MLCK-FIP and wild-type MLCK was tested using three RLC concentrations. Amounts of 
immunoprecipitated kinase were determined using a standard curve of known MLCK concentrations detected by anti-MLCK pAb (bottom). 
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MLCK was also observed within the protruding lamella, lo-
calizing activated MLCK to where significant myosin reor-
ganization occurs. During cell division, MLCK was enriched
at the spindle equator during metaphase and at the poles of
the daughter cells as cleavage furrow contraction was com-
pleted. In addition, observation of areas where MLCK is un-
der represented identifies sites where myosin activity may be
regulated by other pathways.
 
Results
 
Construction of a sensor to detect MLCK localization 
and calmodulin binding state
 
MLCK is activated by calmodulin binding. To detect cal-
modulin binding to MLCK, the FIP was linked to the
MLCK COOH terminus. In the absence of bound calmod-
ulin, the coiled conformation of the calmodulin binding do-
main (CBD) linking the BFP and GFP facilitates FRET
upon BFP excitation (Fig. 1 A). When MLCK-FIP encoun-
ters increased concentrations of [Ca
 
2
 
 
 
]
 
4
 
/calmodulin, the
CBD in both MLCK and the FIP bind calmodulin, chang-
ing its conformation, activating MLCK, and disrupting
FRET. By exciting BFP and monitoring the emission from
GFP, the subcellular localization and the calmodulin-bind-
ing state of MLCK can be simultaneously monitored in liv-
ing cells, allowing us to infer MLCK activation state.
 
MLCK-FIP has wild-type calmodulin-dependent RLC 
kinase activity
 
To test the regulation of MLCK-FIP, we assessed its ability
to phosphorylate RLC. Lysates from COS-7 cells overex-
pressing either wild-type MLCK or MLCK-FIP were in-
cubated with RLC. In the presence of [Ca
 
2
 
 
 
]
 
4
 
/calmodulin,
lysates from wild-type MLCK and MLCK-FIP showed sig-
nificantly higher activities than mock-transfected cell lysates
or when Ca
 
2
 
 
 
 was omitted (Fig. 1 B). This result demon-
strated the [Ca
 
2
 
 
 
]
 
4
 
/calmodulin dependence of the MLCK-
FIP, showing that the FIP did not interfere with normal
MLCK regulation.
To assess the enzymatic properties of MLCK-FIP, we
compared the rates of RLC phosphorylation mediated by
MLCK-FIP or wild-type MLCK at three different subsatu-
rating RLC concentrations. This approach was necessary be-
cause the bacterially expressed RLC precipitated at high con-
centration, limiting our ability to determine MLCK kinetics
at high RLC concentrations. MLCK-FIP and wild-type
MLCK were expressed in COS-7 cells and immunoprecipi-
tated using an MLCK-specific antibody. The amount of re-
combinant MLCK-FIP and wild-type MLCK was deter-
mined by comparing their intensity on an immunoblot to
that of a standard curve (Fig. 1 C, bottom). Since endoge-
nous kinase activity was not detected, the activity in the im-
munoprecipitates represented the expressed kinase activity (a
faint endogenous band of MLCK
 
125
 
 was evident only after
prolonged exposure, unpublished data). Immunoprecipi-
tates containing equal amounts of wild-type MLCK and
MLCK-FIP were used in the in vitro kinase assay. Fig. 1 C
shows that both wild-type MLCK and MLCK-FIP phos-
phorylate RLC at indistinguishable rates at all three sub-
strate concentrations tested. Since the recombinant RLC
was buffered in high salt to prevent precipitation, both wild-
type MLCK and MLCK-FIP–phosphorylated RLC to a
maximum of 1 mol phosphate incorporated per mole RLC,
consistent with previous findings that the MLCK-mediated
diphosphorylation of RLC is sensitive to high ionic strength
(Ikebe and Hartshorne, 1985). These results demonstrate
Figure 2. MLCK-FIP detects [Ca
2 ]4/calmodulin changes in vitro and in vivo. (A) Partially purified MLCK-FIP in buffer containing 1  M 
calmodulin was exposed to increasing free Ca
2 . Emission scans (using 380 nm excitation) were obtained at increasing CaCl2 concentrations. 
(B) COS-7 cells overexpressing MLCK-FIP were treated with 1  M ionomycin, and ratio imaging used to monitor the [Ca
2 ]4/calmodulin 
binding to MLCK-FIP. Relative [Ca
2 ]4/calmodulin binding (representing MLCK activity) is displayed using intensity-modulated display with 
blue indicating bound calmodulin (active MLCK) and red showing little bound calmodulin (inactive MLCK) as shown in the ratio bar. 
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that MLCK-FIP has the same [Ca
 
2
 
 
 
]
 
4
 
/calmodulin-depen-
dent kinase activity as wild-type MLCK.
 
MLCK-FIP detects changes in [Ca
 
2
 
 
 
]
 
4
 
/calmodulin 
concentrations in vitro
 
Next, we ascertained the ability of MLCK-FIP to detect
[Ca
 
2
 
 
 
]
 
4
 
/calmodulin changes in vitro. MLCK-FIP was puri-
fied, and the emission spectrum was determined following
excitation at 380 nm in the presence of increasing amounts
of CaCl
 
2
 
. Fig. 2 A shows that MLCK-FIP displays decreased
FRET, detected by decreased 509 nm emission, in response
to increased [Ca
 
2
 
 
 
] concentration. Decreased GFP emission
was accompanied by a corresponding increase in BFP emis-
sion (448 nm), consistent with loss of FRET. This result,
consistent with the behavior of FIP (Romoser et al., 1997),
shows that MLCK-FIP effectively detects changes in
[Ca
 
2
 
 
 
]
 
4
 
/calmodulin concentration.
 
MLCK-FIP detects [Ca
 
2
 
 
 
]
 
4
 
/calmodulin changes in vivo
 
The simultaneous monitoring of MLCK localization and
[Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding requires two measurements,
one to determine the amount of FRET (corresponding to
activity state) and a second to determine MLCK-FIP inten-
sity (corresponding to distribution). Relative MLCK activity
([Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding state) is represented by a ratio
of intensity from the FRET acceptor (GFP emission at 510
nm caused by stimulation of the donor at 380 nm), F
 
FRET
 
,
divided by the intensity of the acceptor (at 510 nm) pro-
duced by direct stimulation of the acceptor (at 460 nm),
F
 
GFP
 
. Since F
 
GFP
 
 is obtained by direct excitation of the GFP,
the intensity is not affected by FRET, thus providing an in-
dependent measurement of MLCK concentration. How-
ever, it is important to note that F
 
GFP
 
 cannot distinguish be-
tween changes in path length and MLCK concentration.
Regions with significant difference in thickness will have dif-
ference in F
 
GFP
 
 intensities. Caution needs to be applied
when comparing MLCK concentration in cellular regions
with significant difference in thickness.
To test MLCK-FIP detection of [Ca
 
2
 
 
 
]
 
4
 
/calmodulin
changes in live cells, MLCK-FIP spectra were monitored fol-
lowing Ca
 
2
 
 
 
 ionophore, ionomycin, treatment of MLCK-
FIP transfected COS-7 cells. COS-7 cells were chosen be-
cause they significantly overexpress recombinant proteins
and have high transfection efficiency. As shown in Fig. 2 B,
the high protein expression level resulted in a generally dif-
fuse localization of MLCK-FIP. Prior to the ionomycin
treatment, ratio images indicate that MLCK-FIP was not in
the calmodulin-bound state (red, MLCK inactive). A dra-
matic loss of FRET was seen immediately after ionomycin
treatment (Fig. 2 B), indicated by a shift from red to green
or blue, showing that MLCK-FIP bound calmodulin and
was therefore activated. This result shows that MLCK-FIP
detects [Ca
 
2
 
 
 
]
 
4
 
/calmodulin changes in live cells. It also
shows that there was sufficient calmodulin to allow MLCK-
FIP to detect increased [Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding even
when MLCK-FIP was overexpressed.
The data in Fig. 2 B is displayed using Intensity-Modulated
Display (IMD) (Tsien and Harootunian, 1990), in which the
FRET/GFP ratio determines color, and the intensity of the
F
 
GFP
 
 determines the color intensity. In this method, the pixel
 
values 0–255 are divided into 16 bins (0–15, 16–31, etc.) to
represent FRET levels. Within each bin, the lowest number
represents the lowest F
 
GFP
 
 intensity while the highest num-
ber represents the highest intensity. For example, in the 0–15
bin representing the smallest FRET ratio, a pixel value of 0
would represent a small amount of calmodulin-bound MLCK
(activated), while 15 would represent a large amount of cal-
modulin bound MLCK. Similarly, in the 240–255 bin (repre-
senting the highest FRET and therefore the lowest amount of
bound calmodulin or relatively inactive kinase) a value of 240
represents little inactive kinase while 255 represents a large
amount of inactive kinase. This mathematical manipulation pro-
vides a dynamic two-dimensional display of MLCK regulation.
 
Regions with MLCK-FIP activation exhibit highly 
phosphorylated RLC
 
If MLCK-FIP accurately reflects the activation state of
MLCK, cellular regions with [Ca
 
2
 
 
 
]
 
4
 
/calmodulin-bound
Figure 3. MLCK-FIP associates with stress fibers and highlights 
areas of increased RLC phosphorylation. (A) The distribution of RLC 
phosphorylation was assessed by determining the ratio of phosphor-
ylated RLC to total myosin (right) and displayed according to the
ratio bar (bottom right). Myosin with highly phosphorylated RLC is 
indicated in red. MLCK-FIP localization and activity are shown in 
the left panel. Arrows highlight regions of lamellipodia where high 
kinase activity colocalizes with myosin spots. (B) Colocalization of 
MLCK-FIP and rhodamine phallodin–stained stress fibers. Bar, 5  m. 
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MLCK should correspond with regions of increased RLC
phosphorylation. To test this, we compared the MLCK-FIP
ratio image with the distribution of phosphorylated RLC us-
ing a polyclonal antibody specific for RLC phospho-Ser-19
(Matsumura et al., 1998). PTK-2 cells expressing MLCK-
FIP were imaged to obtain a F
 
FRET
 
/F
 
GFP
 
 ratio (Fig. 3 A, left),
then immediately fixed and double-stained for myosin heavy
chain and phosphorylated RLC. The level of RLC phosphor-
ylation is displayed as a ratio of phosphorylated RLC to to-
tal myosin (Fig. 3 A, right). Myosin associated with stress fi-
bers throughout lamella had highly phosphorylated RLC.
The F
 
FRET
 
/F
 
GFP
 
 ratio image shows a strong correlation be-
tween MLCK
 
125
 
 activation and RLC phosphorylation. In
addition, the MLCK-FIP suggests that MLCK is highly ac-
tive within the lamella where very little myosin was ob-
served. In this region, myosin is organized into clusters of bi-
polar filaments that appear as spots undergoing retrograde
movement (Verkhovsky and Borisy, 1993; Verkhovsky et
al., 1995). This pattern of myosin organization within
lamella suggests that there is a pool of diffuse myosin that
becomes more highly organized. The fact that MLCK-FIP is
highly activated in this region suggests that active MLCK
 
125
 
may mediate this myosin reorganization.
Our results suggested that MLCK
 
125
 
 localized to stress fi-
bers. To confirm this, we assessed colocalization of MLCK-
FIP and F-actin by comparing the MLCK-FIP image with
rhodamine-phalloidin staining of fixed cells. Fig. 3 B clearly
shows the colocalization of MLCK-FIP with phalloidin
stained stress fibers.
 
Localized MLCK activation precedes regional
cellular contraction
 
MLCK activation has been implicated in nonmuscle cell
contraction (Goeckeler and Wysolmerski, 1995) and corre-
lates with isometric tension development in permeabilized
endothelial cells (Wysolmerski and Lagunoff, 1991). We ex-
amined how MLCK–calmodulin interaction correlated with
cell contraction in transiently transfected PTK-2 cells.
PTK-2 cells were used because of their high transfection effi-
ciency, prominent stress fiber network, and the fact that they
express MLCK-FIP at significantly lower levels than COS-7
cells, whose ultra-high expression level would have interfered
with the imaging of cytoskeletal structures. Fig. 4 shows two
different examples of contracting PTK2 cells. Cell contrac-
tion was characterized by stress fibers shortening and de-
creased cell margins. The F
 
FRET
 
/F
 
GFP
 
 ratios are displayed in a
three-dimensional plot with color indicating MLCK activity
state as shown in the ratio bar (bottom), and height indicat-
ing fluorescence intensity of directly stimulated GFP. Re-
gions with abundant MLCK-FIP are represented by peaks of
Figure 4. Transient recruitment and 
activation of MLCK125 along contracting 
stress fibers. Ratio images of two 
contracting cells (out of four observed). 
The intensity of MLCK-FIP is represented 
by the peak height (high peaks indicate 
enrichment of MLCK) while the MLCK-FIP 
[Ca
2 ]4/calmodulin-binding state is 
displayed by the color. Red (high ratio) 
represents inactive kinase, while blue 
indicates [Ca
2 ]4/calmodulin-bound 
kinase. Arrows indicate regions where 
diffuse MLCK is recruited to stress fibers, 
and arrow heads show sites of in situ acti-
vation of MLCK-FIP. Please refer to Videos 
1 and 2 (available at http://www.jcb.org/
cgi/content/full/jcb.200110161/DC1) for 
the dynamic MLCK profile. 
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increased height. Fig. 4, A–D, (and Video 1) shows that tran-
sient and highly localized MLCK
 
125
 
 enrichment and appar-
ent activation along stress fibers precedes cellular contrac-
tion. Diffuse MLCK–FIP (Fig. 4 A) became increasingly
associated with stress fibers before contraction (Fig. 4, B and
C, arrows). MLCK–FIP also showed regulated activity in
situ along stress fibers (Fig. 4, B–D, arrowheads), where the
activity first increased at the start of contraction, then de-
creased as contraction ends. Fig. 4, E–H (Video 2), show an-
other example. These results demonstrate that MLCK
 
125
 
 can
associate with stress fibers, although based on previous re-
sults (Poperechnaya et al., 2000) its association with the cy-
toskeleton may be more transient than that of MLCK
 
210
 
.
Videos are available at http://www.jcb.org/cgi/content/full/
jcb.200110161/DC1.
 
MLCK
 
125
 
 is activated in the lamella of migrating cells
 
Since MLCK
 
125
 
 bound calmodulin in the lamella of station-
ary cells, we investigated its behavior in the extending
lamella of PTK2 cells stimulated to migrate by hepatocyte
growth factor/scatter factor. Fig. 5 suggests MLCK activa-
tion in the lamella of motile PTK-2 cells based on increased
calmodulin binding. Since the F
 
FRET
 
 image and the F
 
GFP
 
 im-
age are taken sequentially, we worried that movement might
create a motion artifact that could be misinterpreted as a loss
of FRET (MLCK activation). Two lines of evidence argue
against this. First, extending lamellas continue to show ac-
tive MLCK-FIP (Fig. 3) after fixation. Second, alternating
the order of collection of the FRET and GFP images did not
alter the MLCK-FIP activation profile (unpublished data).
MLCK-FIP in the lamella associated with a meshwork
resembling actin, consistent with MLCK
 
125
 
 binding to
F-actin. The level of MLCK activation was consistently
higher in the leading lamella than the retracting tail (eight
out of nine cells observed), where myosin contractility
has been postulated to dislodge focal adhesions during cell
movement. Previous studies (Matsumura et al., 1998)
showed elevated RLC phosphorylation in the tail, raising the
possibility that MLCK may not be responsible for phosphor-
ylating RLC in the tail. Perhaps one of the other RLC-tar-
geting kinases regulates myosin at the retracting tail.
 
During cytokinesis MLCK
 
125
 
 is activated at both the 
cleavage furrow and the poles
 
Myosin is dramatically reorganized during cytokinesis, with
phosphorylated RLC enriched in the midzone of mitotic
spindle during late anaphase, before the constriction of
cleavage furrow (Matsumura et al., 1998). MLCK
 
210
 
 has
been localized to the cleavage furrow and the cortical regions
of dividing cells, whereas MLCK
 
125
 
 remained diffuse (Pope-
rechnaya et al., 2000). Fig. 6 A shows MLCK-FIP during
cytokinesis in transiently transfected NRK cells. MLCK in-
tensity and FRET profile were measured along a dividing
cell during cytokinesis (dotted red line) and is shown in
Fig. 6 B. Significant MLCK enrichment occurred at late
metaphase (indicated by equatorial alignment of chromo-
somes, phase image not shown) at the equator of the spindle,
and showed moderate levels of calmodulin binding. Imme-
diately before constriction of the cleavage furrow at late
anaphase (red arrowhead, time: 7:30), MLCK
 
125
 
 appeared
maximally activated. The surge of activity at the cleavage
furrow was immediately followed by recruitment of active
MLCK
 
125
 
 to the polar regions of the daughter cells.
MLCK
 
125
 
 intensity at the spindle midzone dropped follow-
ing the onset of cleavage furrow contraction (Fig. 6 B, left),
but was maximally activated until cleavage was complete
(Fig. 6 B, right). MLCK at the poles showed high level of
calmodulin binding especially within the lamella and ruffles.
 
Discussion
 
To extend our understanding of myosin regulation during
cell motility, we produced a biosensor able to both localize
MLCK and provide information regarding its activation
state in living cells. Since MLCK is regulated by [Ca
 
2
 
 
 
]
 
4
 
/cal-
modulin binding, we adopted a strategy to detect colocaliza-
Figure 5. MLCK125 is activated in the lamella. MLCK-FIP shows 
the binding of [Ca
2 ]4/calmodulin to MLCK within the protruding 
lamella of motile (A–D) and stationary (E–H) PTK-2 cells. 
Representative cells (n   10) are shown. H shows enlarged lamella 
region highlighting MLCK125 association with actin-like cytoskeletal 
meshwork. Please refer to Videos 3 and 4 (available at http://
www.jcb.org/cgi/content/full/jcb.200110161/DC1) for the dynamic 
MLCK profile. Arrows show initial tail position. Bar, 5  m. 
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tion of MLCK
 
125
 
 and its activator, [Ca
 
2
 
 
 
]
 
4
 
/calmodulin, by
fusing the FIP to the COOH terminus of MLCK
 
125
 
. Bind-
ing of [Ca
 
2
 
 
 
]
 
4
 
/calmodulin to the regulatory site in MLCK-
FIP activates the kinase (Fig. 1 B) while binding to the FIP
domain disrupts FRET between the GFP-based donor and
acceptor (Fig. 2). We showed that the biosensor retained the
regulation and enzymatic properties of that of wild-type
MLCK, and detected [Ca
 
2
 
 
 
]
 
4
 
/calmodulin changes in vivo.
These results suggest that MLCK-FIP provides an indication
of MLCK activation state in living cells.
Several factors affect the accuracy with which MLCK-FIP
reports MLCK activation state. The first is the requirement
for the two [Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding domains in MLCK-
FIP to have similar calmodulin binding properties. Romoser
et al. (1997) have shown [Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding to
MLCK and FIP to be comparable. A second factor is that
MLCK-FIP must accurately reflect the MLCK localization.
The most distinctive pattern of MLCK localization is its as-
sociation with stress fibers (de Lanerolle et al., 1981; Guerri-
ero et al., 1981; Matsumura et al., 1998; Lin et al., 1999;
Poperechnaya et al., 2000). As shown in Fig. 3 B, MLCK-
FIP shows stress fiber localization. Thus, at least for the
most identifiable sites, MLCK-FIP displays the same local-
ization as wild-type MLCK. Third, to accurately reflect ac-
tivity, MLCK-FIP must also localize to cellular regions with
high levels of RLC phosphorylation. Fig. 3 A shows that re-
gions where myosin RLC is most heavily phosphorylated
also exhibit high levels of MLCK-FIP activation. There are
also regions, particularly the leading edge, where MLCK ac-
tivity is high but where there is relatively little myosin. The
possible reasons for this are discussed below, but there is
generally good agreement between higher levels of RLC
phosphorylation and MLCK-FIP activation.
Since activation state is inferred from calmodulin binding,
could there be situations where calmodulin binding might
not accurately reflect MLCK activation? MLCK is phosphor-
ylated by several kinases, including PAK, CaM kinase II,
and PKA. CaM kinase II or PKA phosphorylation of Ser-
992, which is located in the [Ca
 
2
 
 
 
]
 
4
 
/calmodulin binding do-
main, decreases MLCK
 
125
 
-calmodulin binding efficiency
(Payne et al., 1986; Ikebe and Reardon, 1990; Tansey et al.,
1992). In addition, bound calmodulin blocks phosphoryla-
tion of this site. MLCK is also phosphorylated by PAK at
residues Ser-439 and Ser-991 (Goeckeler et al., 2000). Ser-
439 phosphorylation has been postulated to affect protein–
protein interactions, but there is no direct experimental test
Figure 6. MLCK125 shows bimodal 
distribution during cell division. (A) 
MLCK localization and its state of 
activation during cell division in a 
typical NRK cell (n   8). Arrowhead 
indicates the maximal activation of 
MLCK125 before cleavage furrow 
contraction. (B) The pixel values along 
the dashed red line in A were plotted as 
function of time. FGFP images were used 
to determine the MLCK-FIP intensity. 
FFRET/FGFP values indicated MLCK activity. 
The relative level of MLCK intensity and 
activity were displayed in arbitrary units 
on the z-axis height. Red data lines on 
graphs indicate the onset of cleavage 
furrow contraction. Note the different 
directions on the time axis. MLCK local-
ization to the cleavage furrow decreases 
as cytokinesis continues while MLCK 
activity increases. Changes in MLCK 
intensity may reflect changes in thick-
ness of the cell and/or in MLCK concen-
tration. Please refer to Video 5, available 
at http://www.jcb.org/cgi/content/full/
jcb.200110161/DC1. 
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of this idea. Like Ser-992, calmodulin binding blocks PAK-
mediated phosphorylation of Ser-991 (Goeckeler et al.,
2000). Although it is debatable if PAK phosphorylation re-
duces calmodulin binding (Sanders et al., 1999), it is easy to
imagine that phosphorylation of these sites blocks calmodu-
lin binding and prevents MLCK activation. Ser-991 and
Ser-992 are present in both the calmodulin-binding do-
mains of MLCK-FIP. Thus, if PAK, PKA, or CaM kinase II
were to phosphorylate these sites in both calmodulin-bind-
ing domains, affecting calmodulin binding, the MLCK-FIP
would accurately reflect the activation state of MLCK. On
the other hand, if phosphorylation were to regulate MLCK
independently of calmodulin binding, which has not been
demonstrated, MLCK-FIP might not accurately display the
MLCK activity. Another case where MLCK-FIP might not
accurately reflect MLCK activity is regulation through the
nucleotide-binding domain of the MLCK catalytic core, a
drug target for inhibitors such as KT-5926. Despite these
caveats, our results suggest MLCK-FIP reflects MLCK activ-
ity and provides the best tool available to study the dynamic
regulation of MLCK in vivo.
 
Transient enrichment of calmodulin-bound MLCK
 
125
 
 
induces contraction
 
Although MLCK has been directly implicated in mediating
cellular contraction in permeabilized endothelial cells (Wy-
solmerski and Lagunoff, 1991) and isolated stress fibers
(Katoh et al., 2001), the dynamic aspects of how MLCK
regulates myosin function are poorly understood. This is
complicated by the existence of two isoforms of MLCK. The
vertebrate MLCK gene produces two kinases (Birukov et al.,
1998): (a) a 108–125-kD MLCK (MLCK
 
125
 
) found in both
smooth muscle and nonmuscle cells; and (b) a 210-kD
MLCK (MLCK
 
210
 
), expressed in nonmuscle cells, consisting
of MLCK
 
125
 
 with a 900–amino acid NH
 
2
 
-terminal exten-
sion (Poperechnaya et al., 2000). The MLCK-FIP described
in this report is based on MLCK
 
125
 
, although MLCK
 
210
 
-FIP
is in development. Since antibodies against MLCK
 
125
 
 also
recognize MLCK
 
210, immunolocalization cannot distinguish
between these isoforms. GFP-MLCK210 associates with
stress fibers with high affinity (Poperechnaya et al., 2000),
suggesting it can be activated in situ. GFP-tagged MLCK125
localizes differently in different cell types. Poperechnaya et
al. (2000) showed MLCK125 to be largely diffuse in the cyto-
plasm, while Lin et al. (1997, 1999) observed filament-
bound MLCK125. The short MLCK isoform also contains a
high affinity actin-binding motif (Smith et al., 1999). Con-
sistent with Lin et al. (1997, 1999), we observed MLCK-
FIP in association with stress fibers. We also observed re-
cruitment of additional MLCK-FIP to stress fibers as they
contract (Fig. 4). This suggests that stress fiber association of
MLCK125 may be regulated and transient, providing a basis
to reconcile the previous contradictory observations.
Rho kinase has been proposed to induce a slow and sus-
tained contractility to maintain tension along stress fibers,
whereas MLCK mediates a rapid but transient contraction
(Katoh et al., 2001). The rapid enrichment of MLCK125 ac-
tivity on stress fibers is consistent with in vitro kinetic stud-
ies. The Km of MLCK for RLC is higher than Rho kinase,
suggesting that it may work optimally at high local RLC
concentration. The high Vmax of MLCK is ideal to mediate
rapid myosin activation. Our studies with MLCK-FIP sug-
gest that localized contraction is mediated by a combination
of transient association of MLCK with stress fibers and lo-
calized MLCK activation.
MLCK and directed cell movement
Previous in vitro biochemical studies show that RLC phos-
phorylation mediates myosin assembly into bipolar fila-
ments (Ikebe et al., 1988; Trybus and Lowey, 1988; Katoh
and Morita, 1996). In the leading lamella, apparently diffuse
myosin becomes organized into clusters of bipolar filaments
(DeBiasio et al., 1988; Verkhovsky and Borisy, 1993;
Verkhovsky et al., 1995). Localization of highly activated
MLCK-FIP in this region suggests that MLCK125 could reg-
ulate myosin organization. Consistent with this, reducing
MLCK expression limits lamellipodial extension in smooth
muscle cells after platelet-derived growth factor treatment
(Kishi et al., 2000). Since the protrusion of lamellipodia is
driven mainly by actin polymerization (reviewed in Higgs
and Pollard, 2001), the mechanism by which myosin con-
tributes to motility in the lamella of a migrating cells is un-
clear. Fig. 7 presents a model suggested by the observation of
activated MLCK in the lamella. Myosin II filaments aggre-
gate in the lamella to form ribbon-like structures that may
exert tension required to bundle loosely aligned actin fila-
ments (Verkhovsky et al., 1995). We suggest that MLCK-
mediated myosin activation may lead to contraction in the
region where myosin spots coalesce to form a meshwork of
stress fibers (Fig. 7). Myosin-mediated contraction of the cy-
toskeleton in this region would exert force between the
lamella and cell center as proposed previously (Lauffen-
Figure 7. A model for myosin contraction as a pulling force in 
motility. A schematic illustration of how myosin contraction at the 
front of the nucleus may work synergistically with actin polymerization 
to facilitate movement. Myosin contraction at the convergence zone 
generates a bidirectional pulling force, acting on both the leading 
edge and the cell centroid. The pulling force at the leading front is 
rendered nonproductive by the nascent focal adhesions, turning 
myosin contraction into a productive monodirectional force that 
pulls the centroid forward. Rho kinase–activated myosin may 
mediate tail retraction.Dynamic MLCK–calmodulin interaction in vivo | Chew et al. 551
burger and Horwitz, 1996; Mitchison and Cramer, 1996).
Nascent focal complexes at the leading edge withstand large
traction forces (Beningo et al., 2001), thus anchoring the
lamella. This resistance would convert the myosin-based
contraction into a productive force to pull the nucleus to-
ward the leading edge. Thus, myosin contractility in the
lamella may work in synergy with actin polymerization to
produce directed cell movement.
Myosin activity has been postulated to play a critical role
in producing force for tail retraction (Janson and Taylor,
1993; Worthylake et al., 2001). The presence of highly
phosphorylated RLC supports this hypothesis (Matsumura
et al., 1998). Surprisingly, MLCK activation was seldom ob-
served in the tail region of motile cells. This result raises the
interesting possibility that another RLC-targeting kinase
may be the primary regulator of myosin activity in the tail.
Consistent with this, it has recently been shown that Rho ki-
nase is required and sufficient to mediate monocyte tail re-
traction during transendothelial migration (Worthylake et
al., 2001). These observations highlight the value of MLCK-
FIP, and exemplify how motile cells may compartmentalize
overlapping signaling events.
MLCK is activated in cleavage furrow and cortex 
during cytokinesis
MLCK-FIP has also provided insight into the regulation of
cytokinesis. MLCK-FIP was localized to the spindle mid-
zone during late metaphase before its activation. Calcium
and calmodulin dynamics complement the MLCK dynam-
ics we observe during cytokinesis. Elevation of free Ca
2 
begins in anaphase, and persists through daughter cell sepa-
ration (Tombes and Borisy, 1989). During mitosis, calmod-
ulin is concentrated at the spindle poles and in the cortex
(Li et al., 1999). Cortical calmodulin is redistributed to the
equator before cleavage furrow formation. Using a sensor
(Torok and Trentham, 1994) that detects calmodulin
binding to Ca
2  and its target, only equatorial calmodulin
interacts with downstream effector(s) (Li et al., 1999). En-
richment of MLCK125 at the equator before its activa-
tion suggests that MLCK localization is not dependent
on [Ca
2 ]4/calmodulin. Interaction between MLCK and
[Ca
2 ]4/calmodulin, indicated by loss of FRET, does not
correlate with MLCK-FIP intensity during cytokinesis.
These data argue against the possibility that MLCK-FIP is
mislocalized to regions of high [Ca
2 ]4/calmodulin. The dif-
ferential distribution of Ca
2  and calmodulin in cultured
mammalian cells led to the suggestion that calmodulin
might be involved in positioning of the cleavage furrow (Li
et al., 1999). However, the dynamics of MLCK-FIP suggests
that the contractile machinery may already be in place, and
calmodulin activates contraction locally.
MLCK-FIP accumulated at the midzone until contraction
was initiated. During this time, the MLCK became increas-
ingly associated with calmodulin and thus activated (Fig. 6
A, red arrowhead). Once contraction began, the amount of
MLCK-FIP in the cleavage furrow began to decrease, al-
though what remained was highly activated (Fig. 6 B). As
contraction proceeded, MLCK both accumulated and was
activated at the poles. In contrast, [Ca
2 ]4/calmodulin from
the cortical pool is redistributed to the equator (Li et al.,
1999). The lack of [Ca
2 ]4/calmodulin at the poles of the
daughter cells suggests that MLCK125 may remain active as
the kinase translocates from the equator to the poles. Fol-
lowing cleavage furrow contraction, myosin, monitored by
GFP-RLC, follows a similar translocation from the furrow
to the poles (unpublished data). It is first concentrated at the
equator during late metaphase, and then accumulates at the
poles after constriction of cleavage furrow has occurred. It is
unclear what molecular mechanism is responsible for this re-
distribution. Perhaps MLCK is transported by the same
mechanism as myosin, or even by association with the redis-
tributing myosin.
The localization of active MLCK to the new leading edges
of the daughter cells after cytokinesis is consistent with our
model that myosin is required for the pulling force between
the nucleus and lamellipodia. MLCK recruitment to the
poles where extensive cell spreading occurs may activate my-
osin to facilitate the separation of the two daughter cells in
the same way we suggest myosin contractility might pull the
nucleus forward during migration.
Conclusion
Our data have documented the recruitment of MLCK to
various cytoskeletal structures during contraction, motility,
and cytokinesis. The ability to simultaneously infer MLCK
activity from calmodulin binding and monitor its localiza-
tion highlights the lack of a direct correlation between local-
ization and enzymatic activity, providing an important
reminder that the localization of a protein cannot be auto-
matically translated into its activity. The biosensor can easily
be adapted to study other [Ca
2 ]4/calmodulin-dependent
proteins in vivo, such as calmodulin-dependent protein ki-
nase II. Understanding the spatio-temporal dynamics of
other kinases could advance our understanding of the signal
transduction pathways important for directed cell migration.
Materials and methods
Generating the MLCK-FIP and wild-type MLCK constructs
Both the BFP and GFP cDNAs were PCR-amplified from the appropriate
vectors of the “Living Colors” GFP vector series purchased from CLON-
TECH Laboratories, Inc. Overlapping primers were designed to join the
two fluorophores via a linker GTSSRRKWNKTGHAVRAIGRLSSTGA. Bold
letters denote the [Ca
2 ]4/calmodulin binding domain derived from MLCK,
whereas the rest of the amino acids are linker sequence. Underlined letters
represent MLCK125 Ser-991 and Ser-992 equivalents. The FIP cDNA was
first subcloned into pcDNA3 vector, to generate the pcDNA3/FIP con-
struct. To fuse the MLCK125 cDNA in frame into pcDNA3/FIP, murine
MLCK125 cDNA (EMBL/GenBank/DDBJ accession no. P29294) was PCR
amplified with the downstream primer designed to mutate the stop codon
to code for alanine. The MLCK125 cDNA was then subcloned into BamHI
sites of pcDNA3/FIP, and was sequenced in its entirety to rule out any
PCR-related mutation. The final pcDNA3/MLCK125-FIP construct contains
the murine MLCK125 linked to the FIP via a short linker containing the arbi-
trary amino acid sequence encoded by vector sequence. This construct en-
codes the 185-kD MLCK-FIP recombinant protein.
To generate the pcDNA3 vector expressing the wild-type MLCK125, the
murine MLCK125 was PCR-amplified to engineer the KpnI and BamHI sites
for subcloning into pcDNA3 vector. The positive clones were sequenced
to ensure the absence of PCR-related mutation. The construct expresses
the 125-kD wild-type MLCK125.
Cell culture and transfection
PTK-2 kangaroo rat epithelial cells (a gift from Dr. Robert Goldman, North-
western University, Evanston, IL) were cultured in MEM (GIBCO-BRL) sup-
plemented with 10% FCS, and 0.1 mM nonessential amino acids. The nor-552 The Journal of Cell Biology | Volume 156, Number 3, 2002
mal rat kidney (NRK) epithelial cell line was a gift from Dr. Yu-Li Wang
(University of Massachusetts Medical School, Worcester, MA). NRK cells
were cultured in F12 Kaighn’s modified medium (Sigma-Aldrich), supple-
mented with 10% FCS. COS-7 cells were kindly provided by Dr. Kathleen
Green (Northwestern University, Evanston, IL) and were maintained in
DME supplemented with 10% FCS. All cell lines were maintained in an at-
mosphere of 5% CO2 at 37 C.
Transfection was performed by electroporation. Cells were trypsinized
and pelleted by centrifugation. The cell pellets were resuspended in 1 ml
appropriate medium. 200  l of the resuspended cells were mixed with 7–10
 g DNA containing 13  g sheared salmon sperm DNA and electroporated
in 4-mm cuvettes using Bio-Rad Laboratories Gene Pulser set at 200 ohms,
960  FD, 250 V. Using this method, we achieved high transfection effi-
ciencies (70–90%) for most cell types at a wide range of cell density except
NRK cells, in which  10–15% could be transfected. Peak protein expres-
sion levels observed 18–48 h posttransfection for all cell lines.
Reagents, proteins, and antibodies
Polyclonal rabbit anti-MLCK antibody and purified MLCK125 were pro-
vided by Dr. Robert Wysolmerski (St. Louis University, St. Louis, MO). Ion-
omycin and calmodulin were purchased from Calbiochem. Protein-A
sepharose was purchased from Amersham Pharmacia Biotech. pp2b rabbit
polyclonal antibody specific for Ser-19–phosphorylated RLC was obtained
from Dr. Fumio Matsumura. Monoclonal antimyosin heavy chain antibody
was purchased from Covance. Texas red–conjugated goat anti–mouse IgM
and Cy5-conjugated donkey anti–rabbit IgG were purchased from Jackson
ImmunoResearch Laboratories.
Protein expression and purification
Myosin II RLC cDNA was cloned into pET14b vector (Novagen) for the ex-
pression of His-tagged RLC, and protein expression was induced in BL21
by 0.4 mM IPTG for 3 h. Bacterial pellet was lysed in lysis buffer A (5 mM
imidazole, 0.5 NaCl, 20 mM Tris-HCl, pH 7.9) containing 6 M urea and
protease inhibitors. Following sonication, cell lysate was precleared by
20,000 g centrifugation, and loaded onto His-Bind column (Novagen) pre-
equilibrated with the same buffer. After washing the column with washing
buffer A (60 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9), protein
was eluted using elution buffer A (500 mM imidazole, 250 mM NaCl, 10
mM Tris-HCl, pH 7.9). The eluted protein was dialyzed against dialysis
buffer A (20 mM MOPS, pH 7.2, 250 mM NaCl, 1 mM CaCl2, 1 mM
MgCl2) with stepwise decrease of imidazole concentration from 500 to 250
mM. Lower imidazole concentration resulted in massive protein precipita-
tion. Cleaving the His tag did not eradicate the precipitation problem.
MLCK-FIP and wild-type MLCK were overexpressed in COS-7 cells for
purification. Cell lysates were collected from 16 confluent 10-cm cell cul-
ture dishes. Cells were lysed in 35 ml of lysis buffer B (10 mM MOPS, pH
6.8, 5 mM MgCl2, 1.25 mM EGTA, 1 mM EDTA, 10% glycerol, 1% NP-40)
containing protease inhibitors. Lysates were sonicated briefly in sonicator
waterbath and precleared with 50,000 g centrifugation, and purified using
Mono-Q ion exchange chromatography preequilibrated with lysis buffer B
without NP-40 and glycerol. The column was washed with 2 vol of equili-
bration buffer and the proteins eluted against a gradient of 0–600 mM
NaCl in elution buffer B (10 mM MOPS, pH 6.8, 5 mM MgCl2, 1.25 mM
EGTA, 1 mM EDTA). Analysis of the elution profile showed that MLCK-FIP
and wild-type MLCK were reproducibly eluted three fractions apart from
one another, thus allowing us to separate MLCK-FIP from endogenous
wild-type MLCK.
In vitro FRET analysis
In vitro spectrofluorimetric analysis of MLCK-FIP was performed using an
AMINCO Bowman Series 2 Luminescence Spectrometer. An excitation
wavelength of 380 nm was used throughout the experiment. Purified
MLCK-FIP was assayed in 1 ml reaction mixture containing 20 mM MOPS
buffer, pH 7.2, 10 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 1  M cal-
modulin. Standard CaCl2 solution was added to the cuvette to titrate the ef-
fects of increasing [Ca
2 ]4/calmodulin. The free Ca
2  available for binding
to calmodulin is calculated by MaxChelator program, taking into account
all divalent cations and their chelators in the buffer. An emission scan from
430 nm to 540 nM was performed with each addition of CaCl2.
RLC phosphorylation
To compare the rate of RLC phosphorylation catalyzed by MLCK-FIP with
that by wild-type MLCK, the recombinant kinases were transiently overex-
pressed in COS-7 cells and immunoprecipitated using rabbit polyclonal
anti-MLCK antibody. The amount of immunoprecipitated MLCK was esti-
mated by comparing the densitometric units of the MLCK bands on immu-
noblot to that of a standard curve set up by varying amount of recombinant
MLCK125. Immunoprecipitate containing 1  g kinase was used in the in
vitro kinase assay. The fact that our recombinant RLC precipitates at low
salt and high protein concentration precludes the accurate determination
of Vmax and Km by conventional method. Instead we compared the rate
of phosphorylation by MLCK-FIP and wild-type MLCK at three substrate
concentrations. Kinase assay was performed in 25 mM Tris-HCl, pH 7.5, 5
mM MgCl2, 1 mM DTT, 0.5 mM CaCl2, 100 mM KCl, and 1  M calmodu-
lin. Specific activity of 
32P- -ATP was 4,000 cpm/pmole. 5  l of the reac-
tion was removed at the indicated time points and spotted onto Whatman
P81 ion exchange paper, and the reaction stopped by ice-cold 10%
trichloroacetic acid containing 2% sodium pyrophosphate. The papers
were washed four times in ice-cold acetone, heated to 80 C for 15 min,
and washed once with acetone to remove heat-labile phosphate. The sam-
ples were then counted in scintillation counter.
Live cell imaging
Live cell imaging was performed on ZEISS Axiovert S100-TV inverted fluo-
rescent microscope. Rapid switching of fluorescent wavelength was ac-
complished by emission and excitation filter wheels controlled by Sutter
Instruments Lambda 10 controller, and the shutters were controlled by Un-
iblitz VMM-D1 shutter drivers. Digital fluorescent images were captured
by Micromax cooled CCD camera (Princeton Instruments) with a 512  
512 camera chip. Filter wheels are equipped with bandpass filters for BFP
and GFP with a stationary dual beamsplitter for BFP and GFP located in
the filter block. Filters were purchased from Chroma. Live cells were im-
aged in a Bioptechs FCS2 closed chamber system maintained at 37 C, with
a chamber thickness of 0.75 mm. To reduce the background fluorescence
and to image cell in the absence of CO2, the cell medium was mixed with
equal volume of Leibovitz L-15 medium without Phenol Red (GIBCO-BRL)
supplemented with 10% FCS. Fresh medium was perfused at 0.1 ml/min
into the chamber during imaging.
Cell images were taken using MetaMorph 4.5 (Universal Imaging Corp.)
software. The images were taken with 200–300 ms exposure with  50 ms
interval between the numerator FFRET and the denominator FGFP images. Ra-
tio images were constructed by displaying the ratio in 16 different color
hues with the lowest ratio (MLCK active) displayed at the blue end of the
ratio spectrum. Using the intensity of the denominator (which served as the
internal control irrespective of FRET), the ratio colors were displayed in
sixteen different intensity levels by the Intensity Modulatory Display mode
(Fig. 2 B). Therefore, depending on the enrichment and the activation state
of MLCK-FIP at any given subcellular region, the color of the ratio denotes
the relative extent at which MLCK-FIP associates with [Ca
2 ]4/calmodulin,
while the intensity of that ratio color represents the amount of MLCK-FIP
being localized by the cell. To highlight the dynamic recruitment of
MLCK125 to cytoskeletal structures, FRET ratio was plotted against the in-
tensity profile, whereby the pixel intensity was represented by line height,
and the FRET ratio depicted by the line color. We have avoided cells with
saturated pixels to minimize error on ratio calculation.
To correlate the relative activity of MLCK-FIP with the extent of RLC
phosphorylation in vivo, PTK-2 cells transiently expressing MLCK-FIP were
plated on gridded coverslips. The ratio images of MLCK-FIP were obtained
as described, and the cells were immediately fixed. The coverslips were
blocked with PBS containing 0.1% BSA and 1:20 dilution of normal goat
serum. Double immunofluorescence was performed with antimyosin mAb
and pp2b polyclonal antiphosphorylated RLC antibody. Primary antibody
incubation performed at 37 C for 1 h. After washing in PBS, the secondary
antibody was performed at 37 C for 30 min with Texas red–conjugated
goat anti–mouse IgM, and Cy5-conjugated donkey anti–rabbit IgG. Immu-
nolocalization images were taken with ZEISS LSM 510 confocal micro-
scope and ratio of the images performed on MetaMorph 4.5.
Online supplemental materials
There are videos relating to Figs. 4–6 available online. Video 1 corre-
sponds to Fig. 4, A–D; Video 2 corresponds to Fig. 4, E–H; Video 3 corre-
sponds to Fig. 5, A–D; Video 4 corresponds to Fig. 5, E–H; and Video 5
corresponds to Fig. 6.
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